Patient-reported outcomes of adalimumab, phototherapy, and placebo in the vascular inflammation in psoriasis trial: A randomized controlled study
Journal of the American Academy of Dermatology | Aug 14, 2019
Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study
Journal of the American Academy of Dermatology | Aug 04, 2019